Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL69P is a pseudogene that is highly homologous to the functional 7SL RNA gene, which encodes a non-coding RNA component of the cytoplasmic Signal Recognition Particle (SRP). Unlike its parent functional gene, RN7SL69P does not produce protein and is not known to encode a functional RNA product[1][4][6]. Pseudogenes of 7SL RNA are derived from reverse transcription and genomic insertion of 7SL RNA cDNA and often accumulate mutations or truncations that render them transcriptionally inactive or non-functional[5]. While some pseudogenes in general may exert regulatory functions via noncoding RNAs or as microRNA decoys[2], there is no evidence that RN7SL69P has such biological utility. Its relevance to therapeutics, disease biology, drug interaction, or biomarker development is negligible.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 69, pseudogene (RN7SL69P).